The content of IL-1b, IL-4, IL-6, IL-10, TNF-α and IFNγ in bladder cancer depend by a tumor grade

V. Dmytryk, A. Vyshenska, I. Proshkina, O. Savchuk, P. Yakovlev, T. Andriichuk
Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv; Taras Shevchenko National University of Kyiv, Kyiv


Bladder cancer (BC) is the 9th most commonly diagnosed cancer worldwide, with the highest rates in developed countries. About ¾ of the
patients are men. The risk of developing of malignancies increases with chronic inflammation. Chronic inflammation can be caused by
infections, autoimmune diseases and other factors. In conditions of chronic inflammation, cytokines are involved in leukocyte recruitment due to enhanced expression of cell adhesion molecules and chemoattraction. Cytokines are involved in the inflammatory response, for example, they are the main determinants of cellular infiltration, cellular activation and systemic response to inflammation. It is now well established that the role of cytokines is to participate in many aspects of biology, including malignancies. Cytokines can be secreted not only by
proinflammatory cells but also by stromal cells and malignant cells, thus establishing a network with various factors that may be involved in
the development of BC. The progression of BC causes an imbalance between local and general immunity. The relationship between neoplastic
cells and their microenvironment is essential in the proliferation and invasion of malignant cells. The purpose of this work was to determine the content of cytokines IL-1b, IL-4, IL-6, IL-10, TNF-α and IFNγ in tumor tissues, depending on the grade of cell differentiation. In our study the content of IL-1b, IL-4, IL-6, IL-10 was higher in the wall samples of bladder cancer tissues in patients with G3-4 grade BC, which may be an important characteristic of malignant cells in BC, and explain the high invasiveness of BC. The content of TNF-α, IFNγ did not significantly change depending on grade. The data of our study are consistent with the data of previous studies conducted in the study of other neoplasms, which indicate the relationship of the studied indicators with the development of cancer.


bladder cancer, cytokines, inflammation, ELISA.

Full Text:



Agarwal A, Agrawal U, Verma S. et al. Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy. Immunopharmacol Immunotoxicol. 2010; 32:348–56

Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: canceras a paradigm. NatImmunol. 2010; 11:889–896. [PubMed: 2085622]

Bonin S, Brunetti D, Benedetti E, Dotti I, Gorji N, Stanta G. Molecular characterisation of breast cancer patients at high and low recurrence risk. Virchows Arch. 2008;452(3):241 – 250.

Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. / 1. Bradford. // 1. – 1976. – № 72. – С. 248–254.

Chen MF, Lin PY, Wu CF, Chen WC, Wu CT. IL-6 expression regulates tumorigenicity and correlates with prognos is in bladder cancer [published correction appear sin PLoSOne. 2016;11(5):e0155774]. PLoSOne. 2013;8(4):e61901. Published 2013 Apr 30. doi:10.1371/journal.pone.0061901

Goldstein R, Hanley C, Morris J, et al. Clinical investigation of the role of interleukin‐4 and interleukin-13 in the evolution of prostate cancer. Cancers (Basel). 2011; 3:4281–4293.

Grivennikov SI, Karin M. Inflammatory cytokines in cancer: Tumour necrosis factor and interleukin 6 take the stage. Ann Rheum Dis. 2011;70(Suppl 1): i104–i108. doi: 10.1136/ard.2010.140145.

Ishchuk T.V. Plasma levels of MMPs and TIMP-1 in urinary bladder cancer patients. / [T. V. Ishchuk, D. Glavachek, O. M. Savchuk та ін.]. // Biomedical Research and Therapy. – 2018. – № 5. – С. 1931–1940.

Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther. 2006;8 Suppl 2: S2.

Konjevic G, Radenkovic S, Srdic T, Jurisic V, Stamatovic Lj, Milovic M. Association of decreased NK cell activity and IFN? expression with pSTAT dysregulation in breast cancer patients. J BUON. 2011;16(2):219-226

Kozakowska M, Dobrowolska-Glazar B, Okoń K, et al. Preliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder Cancer. J Clin Med. 2016;5(3):29. Published 2016 Feb 25. doi:10.3390/jcm5030029

Ng TH, Britton GJ, Hill EV, et al. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol. 2013; 4:129. Published 2013 May 31. doi:10.3389/fimmu.2013.00129

Okada F. Inflammation-related carcinogenesis: current findings in epidemiological trends, causes and mechanisms. YonagoActa Med. 2014;57(2):65-72.

Okamoto M, Lee C, Oyasu R. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res. 1997;57(1):141–146.

Tao L, Qiu J, Jiang M, etal. Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFaSignals. MolCancerTher. 2016;15(8):1943–1951. doi:10.1158/1535-7163.MCT-15-0306

Turner MD, Nedjai B, Hurst T, et al. Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 2014; 1843: 2563–2582

Verronèse E, Delgado A, Valladeau-Guilemond J, Garin G, Guillemaut S, Tredan O. Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay. Oncoimmunology. 2016;5(3):e1100791. doi:10.1080/2162402X.2015.1100791.

Wang M, Zhao J, Zhang L, et al. Role of tumor microenvironment in tumorigenesis. J Cancer. 2017;8(5):761-773. Published 2017 Feb 25. doi:10.7150/jca.17648

Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes?. Acta Pharmacol Sin. 2008;29(11):1275–1288. doi:10.1111/j.1745-7254.2008.00889.x

Yaacoub K, Pedeux R, Tarte K, Guillaudeux T. Role of the tumor microenvironment in regulating apoptosis and cancer progression. Cancer Lett. 2016;378(2):150-159. doi:10.1016/j.canlet.2016.05.012.

Yoshida, Takahiro&Kates, Max&Sopko, Nikolai&Liu, Xiaopu&Singh, Alok& R. Bishai, William&Joice, Gregory& J. McConkey, David& J. Bivalacqua, Trinity. (2017). Ex vivo culture of tumor cells from N-methyl-N-nitrosourea–induced bladder cancer in rats: Development of organoids and an immortalized cell line. Urologic Oncology: Seminars and Original Investigations. 36. 10.1016/j.urolonc.2017.11.024.

Received: 01.10.2019

Revised: 02.11.2019

Signed for press: 03.11.2019



  • There are currently no refbacks.

Лицензия Creative Commons
This journal is available according to the Creative Commons License «Attribution» («Атрибуція») 4.0 Global (CC-BY).